President and Chief Executive Officer · Kronos Bio, Inc. (KRON)

Norbert Bischofberger

A named executive officer of Kronos Bio in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,761,537

Salary $580,000

FY2022: $2,796,660

1st of 3 named executive officers at Kronos Bio by FY2023 total.

3 named officers on file for Kronos Bio, FY2023

Norbert Bischofberger’s pay file — $29

  • 2 fiscal years of pay, line by line
  • KRON’s disclosed peer group of 24 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Kronos Bio’s whole pay program stands against its peers

  • Kronos Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on KRON→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2024 (DEF 14A).

Free

Get Norbert Bischofberger’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Norbert Bischofberger compensation by year

Kronos Bio Summary Compensation Table · all 2 fiscal years held
In US dollars, as Kronos Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$580,000$580,000
Bonus$0$0
Stock awards$0—
Option awards$1,986,960$849,337
Non-equity incentive$217,500$319,000
Pension and deferred compensation$0$0
All other$12,200$13,200
Total$2,796,660$1,761,537

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Kronos Bio, Inc. DEF 14A filed April 29, 2024, accession 0001140361-24-023006, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Kronos Bio, Inc. filed document, accession 0001140361-24-023006. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.

$2.8M
$1.8M
FY22
FY23
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU14,150$17,688—
Option216,667—$7.30
Option451,938—$2.09
Option74,297—$30.78

Per the Outstanding Equity Awards at Fiscal Year-End table in Kronos Bio, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Kronos Bio’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Norbert Bischofberger · this pagePresident and Chief Executive Officer$1,761,537
Barbara KosaczFormer Chief Operating Officer and General Counsel$1,306,466
Jorge DiMartinoFormer Chief Medical Officer and Executive Vice President, Clinical Development$1,286,684

Board service

Kronos Bio board · FY2023

How this board is paid

Company policy: Kronos Bio pays directors a $40,000 cash retainer and $335,000 in Options/RSUs. As stated in Kronos Bio's FY2023 proxy.

The full Kronos Bio compensation record

free company brief

This page is one person within Kronos Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Kronos Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Norbert Bischofberger's compensation dossier · One-time report. No refunds.